Live Breaking News & Updates on Oncology Program Updates

Stay updated with breaking news from Oncology program updates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Veru Inc.: Veru Reports Fiscal 2023 First Quarter Financial Results

Sabizabulin for moderate to severe COVID-19 under review for potential emergency authorization by multiple global regulatory agencies Presented late-breaker oral presentation at IDWeek; sabizabulin treatment ....

United States , South Korea , United Kingdom , Mitchell Steiner , Samuel Fisch , Hannah Gendel , Schwierige Zeiten , Eli Lilly , Sexual Health Program Updates , Oncology Program Updates , Canada Health , European Union Medicines Agency , Australia Therapeutic Goods Administration , European Union , Veru Inc , Korea Ministry Of Food , Drug Administration , Infectious Disease Program Updates , Regulatory Agency , Company Form , Exchange Commission , Corporate Communications , Chief Executive Officer , Novel Oralmicrotubule Disruptor , Hospitalized Moderate , High Risk ,